These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3817343)

  • 41. [Etretinate in the treatment of psoriasis and other skin diseases].
    Kansky A; Paljan D
    Lijec Vjesn; 1983 Oct; 105(10):412-4. PubMed ID: 6656529
    [No Abstract]   [Full Text] [Related]  

  • 42. Etretinate therapy and thrombocytopenia.
    Naldi L; Rozzoni M; Finazzi G; Pini P; Marchesi L; Cainelli T
    Br J Dermatol; 1991 Apr; 124(4):395. PubMed ID: 2025567
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of Etretinate on the neutrophil chemotaxis in pustular psoriasis.
    Pigatto PD; Brugo AM; Finzi AF
    Boll Ist Sieroter Milan; 1982 May; 61(2):112-5. PubMed ID: 7126334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etretinate-induced skeletal muscle damage.
    Hodak E; David M; Gadoth N; Sandbank M
    Br J Dermatol; 1987 May; 116(5):623-6. PubMed ID: 2954577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sarcoid-like granuloma following prolonged etretinate treatment.
    Fernández-Redondo V; Vázquez J; Sánchez-Aguilar D; Toribio J
    Dermatology; 1994; 188(3):226-7. PubMed ID: 8186514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Excess granulation tissue during etretinate therapy.
    Hodak E; David M; Feuerman EJ
    J Am Acad Dermatol; 1984 Dec; 11(6):1166-7. PubMed ID: 6512060
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dermatoses difficult to treat. Their treatment with an aromatic retinoid (etretinate)].
    Solano E; Hidalgo H
    Med Cutan Ibero Lat Am; 1983; 11(5):369-71. PubMed ID: 6230492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Tigason in psoriasis. Advantage of progressively increasing doses].
    Dubertret L
    Ann Dermatol Venereol; 1985; 112(3):289-90. PubMed ID: 4062173
    [No Abstract]   [Full Text] [Related]  

  • 50. Case of the month: " ... or plat du jour".
    Bhattacharya J; Fraser C; MacDonald LM
    Br J Radiol; 1995 May; 68(809):545-6. PubMed ID: 7788246
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatocanalicular injury associated with vitamin A derivative etretinate. An idiosyncratic hypersensitivity reaction.
    Khouri MR; Saul SH; Dlugosz AA; Soloway RD
    Dig Dis Sci; 1987 Oct; 32(10):1207-11. PubMed ID: 3652901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etretinate therapy.
    Baran R
    Arch Dermatol; 1984 Aug; 120(8):993. PubMed ID: 6465922
    [No Abstract]   [Full Text] [Related]  

  • 53. Etretinate and visual function: a 1-year follow-up study.
    Pitts JF; Mackie RM; Dutton GN; McClure EA; Allan D
    Br J Dermatol; 1991 Jul; 125(1):53-5. PubMed ID: 1873203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A.
    Schopf RE; Hultsch T; Lotz J; Bräutigam M
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapeutic assessment and side-effects of the aromatic retinoid on the nail apparatus].
    Baran R
    Ann Dermatol Venereol; 1982; 109(4):367-71. PubMed ID: 7125489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 57. [Tigason in the treatment of psoriasis and various dermatoses].
    Kalamkarian AA; Marzeeva GI; Chistiakova IA; Kirsanova MM; Mel'kumov AV
    Vestn Dermatol Venerol; 1985 Jul; (7):4-7. PubMed ID: 4050091
    [No Abstract]   [Full Text] [Related]  

  • 58. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
    Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etretinate and pregnancy.
    Lammer E
    Lancet; 1989 Jan; 1(8629):109. PubMed ID: 2562875
    [No Abstract]   [Full Text] [Related]  

  • 60. Re-PUVA.
    Lassus A
    Photodermatol; 1984 Dec; 1(6):263-4. PubMed ID: 6533618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.